From: Neuronal hypoxia in vitro: Investigation of therapeutic principles of HUCB-MNC and CD133+stem cells
Cellular fractions of | Markers | Content in tMNC (%) | Content in CD133- (%) |
---|---|---|---|
I) Myeloid cells | CD14+/CD45+ | 14.1 ± 4.4 | 19.5 ± 2.4 |
II) Lymphocytes (including stem cells) | 85.9 ± 4.4 | 80.5 ± 2.4 | |
Subpopulations of II | |||
B-lymphocytes | CD19+/CD45+ | 12.3 ± 5.5 | 14.6 ± 0.5 |
T-lymphocytes | CD3+/CD45+ | 73.0 ± 10.2 | 76.8 ± 1.9 |
NK-cells | CD56+/CD45+ | 12.7 ± 4.5 | 8.3 ± 1.4 |
Hematopoietic stem/progenitor cells | CD133+/CD34+ | 1.2 ± 1.0 | 0.03 ± 0.01 |
CD133+/CD34- | 0.4 ± 0.2 | 0.03 ± 0.02 | |
CD133-/CD34+ | 0.4 ± 0.2 | 0.34 ± 0.06 |